Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update
Files in This Item:
|pharmaceutics-11-00041.pdf||982.83 kB||Adobe PDF||Download|
|Title:||Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update||Authors:||Maher, Sam; Brayden, David J.; Casettari, Luca; Illum, Lisbeth; et al.||Permanent link:||http://hdl.handle.net/10197/10707||Date:||19-Jan-2019||Online since:||2019-05-29T10:19:32Z||Abstract:||The application of permeation enhancers (PEs) to improve transport of poorly absorbed active pharmaceutical ingredients across the intestinal epithelium is a widely tested approach. Several hundred compounds have been shown to alter the epithelial barrier, and although the research emphasis has broadened to encompass a role for nanoparticle approaches, PEs represent a key constituent of conventional oral formulations that have progressed to clinical testing. In this review, we highlight promising PEs in early development, summarize the current state of the art, and highlight challenges to the translation of PE-based delivery systems into safe and effective oral dosage forms for patients.||Funding Details:||Science Foundation Ireland||Type of material:||Journal Article||Publisher:||MDPI||Journal:||Pharmaceutics||Volume:||11||Issue:||1||Start page:||1||End page:||23||Copyright (published version):||2019 the Authors||Keywords:||Permeation enhancer; Oral delivery; Formulation; Permeability; Safety; Simulated intestinal fluid; Hydrophobization; Epithelium||DOI:||10.3390/pharmaceutics11010041||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Veterinary Medicine Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.